Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mallinckrodt PLC MNKTQ

Mallinckrodt plc develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and... see more

Recent & Breaking News (OTCPK:MNKTQ)

Mallinckrodt Shareholder Notice

Newsfile July 23, 2023

MALLINCKRODT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options

PR Newswire July 22, 2023

Mallinckrodt Shareholder Action Reminder

Newsfile July 21, 2023

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc (MNK) Investors

Business Wire July 21, 2023

Mallinckrodt Deadline Alert

Newsfile July 20, 2023

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc (MNK) Investors

Business Wire July 20, 2023

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc (MNK) Investors

Business Wire July 20, 2023

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors

Business Wire July 19, 2023

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors

Business Wire July 19, 2023

Mallinckrodt Shareholder Action Reminder

Newsfile July 18, 2023

Mallinckrodt Deadline Alert

Newsfile July 17, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK

PR Newswire July 17, 2023

Mallinckrodt Shareholder Notice

Newsfile July 16, 2023

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK

Newsfile July 15, 2023

MALLINCKRODT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options

PR Newswire July 15, 2023

Mallinckrodt Shareholder Action Reminder

Newsfile July 14, 2023

The Law Offices of Frank R. Cruz Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors

Business Wire July 14, 2023

Mallinckrodt Deadline Alert

Newsfile July 13, 2023

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Mallinckrodt plc Investors with Over $1 Million in Losses to Secure Counsel Before Important Deadline in Securities Class Action - MNK, MNKPF

Business Wire July 13, 2023

Calling All Mallinckrodt plc (MNK) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!

Business Wire July 13, 2023